Galip Can Uyar/LinkedIn
Jun 25, 2025, 21:21
Galip Can Uyar: Ovarian Cancer Treatment Is Entering a New Era
Galip Can Uyar, Medical Doctor at Etlik City Hospital, shared a post on X:
“Ovarian cancer treatment is entering a new era!
In 89% of primary tumors, at least one ADC target (FRα, HER2, CDH6, TROP2, B7-H4) showed high expression.
Post-chemotherapy expression remained largely stable, opening doors for more durable, personalized ADC strategies in HGSOC.
Multi-target expression in 55% → Potential for combination therapies.
Highlights the urgent need to translate biomarker profiling into real-world impact.”
More posts featuring Galip Can Uyar on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 5, 2025, 19:11
Aug 5, 2025, 18:55
Aug 5, 2025, 18:30
Aug 5, 2025, 18:18
Aug 5, 2025, 18:04
Aug 5, 2025, 17:52
Aug 5, 2025, 16:29